Among patients with specific cancers, yields were 9.7, 13.4, and 14.8% in patients with breast, ovarian, and colon/stomach cancer, respectively (the patients with breast or ovarian cancer did not report previous BRCA1/2 testing). The gene discussed is BRCA1; the disease is ovarian carcinoma.